Author:
Li Jiaqi,Zheng Zhijian,Deng Hao,Men Yi,Chen Yu,Han Qi
Abstract
Abstract
Background
Extraskeletal myxoid chondrosarcoma (EMC) is a rare malignant tumor described in the head and neck region, especially in the gingival. We present one case arising in the gingival of right mandible, and briefly reviewed the related literature.
Case presentation
A 24-year-old male patient with a lesion of 3.5*2.0 cm in buccal gingival of right posterior mandible for 2 months. The tumor was composed of cartilaginous structures and myxoid matrix. Immunohistochemical(IHC) showed that the tumor cells to be positive for vimentin, focally positive for S-100, negative for calponin, SMA, SOX10. The Ki-67 labelling index was 80%. Fluorescent in situ Hybridization (FISH) was positive for NR4A3 rearrangement.
Conclusions
Due to its unusual site and low incidence in the oral region, a combination of histological findings, immunohistochemistry, and molecular pathology as well as differential diagnosis with other diseases should be taken into consideration in the process of clinical diagnosis and treatment.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Histology,Pathology and Forensic Medicine
Reference40 articles.
1. Romañach MJ, Carlos R, Nuyens M, de Andrade BA, de Almeida OP. Extraskeletal myxoid chondrosarcoma of the masticator space in a pediatric patient. J Clin Exp Dent. 2017;9(6):e825–31.
2. Garde JB, Palaskar SJ, Kathuriya PT. Extraskeletal myxoid chondrosarcoma of maxilla: A rare entity. J Oral Maxillofac Pathol. 2016;20(1):151–3.
3. Goh YW, Spagnolo DV, Platten M, Caterina P, Fisher C, Oliveira AM, Nascimento AG. Extraskeletal myxoid chondrosarcoma: a light microscopic, immuno-histochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation. Histopathology. 2001;39(5):514–24.
4. Brenca M, Stacchiotti S, Fassetta K, Sbaraglia M, Janjusevic M, Racanelli D, Polano M, Rossi S, Brich S, Dagrada GP, Collini P, Colombo C, Gronchi A, Astolfi A, Indio V, Pantaleo MA, Picci P, Casali PG, Dei Tos AP, Pilotti S, Maestro R. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas. J Pathol. 2019;249(1):90–101.
5. Chen Y, Zhang Y. Myxoid chondrosarcoma of the mandible in a 22-year-old man: a case report. Mol Clin Oncol. 2016;5(3):237–40.